FdaApplication
ANDA 203599
Identifiers
- fda_app_no: ANDA203599
Properties
| Property | Value |
|---|---|
| applicant_name | SOFGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2016-09-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBUPROFEN | IBUPROFEN | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE;ORAL |
1 product